Related Posts
-
Use of Biomarkers to Improve Immunosuppressive Drug Development and Outcomes in Renal Organ Transplantation: A Meeting Report -
On September 25th, the FDA published a Personal Viewpoint in the American Journal of Transplantation
-
The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients